Deep Breathing Techniques (Pranayama) in Pregnancy

Sponsor
Children's Mercy Hospital Kansas City (Other)
Overall Status
Recruiting
CT.gov ID
NCT05341921
Collaborator
(none)
90
1
6
28
3.2

Study Details

Study Description

Brief Summary

Slow deep breathing actives the vagal nerve and leads to a natural reduction in physiological parameters such as blood pressure, heart rate and digestion. The effects of these techniques have not been assessed in pregnancy. The primary objective is to assess the effects of various yogic deep breathing techniques on blood pressure during pregnancy. The breathing exercises will include Alternate nostril breathing, Bhramari breathing, and Sheetali breathing. A secondary objective will be to assess the effects of these breathing exercises on other physiological parameters including heart rate, heart rate variability, body temperature, cardiac output, vascular resistance and respiratory rate.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Alternate Nostril Breathing
  • Behavioral: Bhramari Breathing
  • Behavioral: Sheetali Breathing
N/A

Detailed Description

The trial will be conducted as a pilot study in one study visit, which will be conducted in two phases. Phase I will be conducted on normotensive pregnant women and Phase II will be conducted on hypertensive pregnant women. Participants will be in their third trimester of pregnancy (28 weeks onwards).

Upon presentation, they will be randomized into one of three groups: Alternate nostril breathing, Bhramari breathing or Sheetali breathing. Maternal monitoring devices will be placed on the patient before the intervention. The fetus will be monitored by external monitors consisting of a fetal heart rate monitor and tocodynamometer to assess uterine activity. Fetal position will be assessed before and after the intervention by ultrasound. All devices will obtain a reading for 15 minutes before, during and after the intervention.

Intervention: In an upright, seated position, the participant will engage in a total of 15 minutes of one deep breathing technique. The breathing practice will be conducted in three, 5-minute increments with a one-minute break between each session. These breathing techniques are easy to learn and participants will be taught how to perform the exercise (visual demonstration, verbal and written instructions will be provided). Participants will be given the opportunity to practice the breathing technique and ask any questions prior to initiating monitoring.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
90 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Pilot, randomized, controlled trialPilot, randomized, controlled trial
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
The Acute Effects of Pranayama (Deep Breathing Techniques) on Physiological Parameters in Pregnancy
Anticipated Study Start Date :
Aug 1, 2022
Anticipated Primary Completion Date :
Jun 1, 2024
Anticipated Study Completion Date :
Dec 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Alternate Nostril Breathing Phase I

Alternate nostril breathing for normotensive women in 3rd trimester of pregnancy

Behavioral: Alternate Nostril Breathing
Utilizing Pranayama (deep breathing technique) in normotensive and hypertensive women in 3rd trimester of pregnancy

Active Comparator: Bhramari Breathing Phase I

Bhramari breathing for normotensive women in 3rd trimester of pregnancy

Behavioral: Bhramari Breathing
Utilizing Pranayama (deep breathing technique) in normotensive and hypertensive women in 3rd trimester of pregnancy

Active Comparator: Sheetali Breathing Phase I

Sheetali breathing for normotensive women in 3rd trimester of pregnancy

Behavioral: Sheetali Breathing
Utilizing Pranayama (deep breathing technique) in normotensive and hypertensive women in 3rd trimester of pregnancy

Active Comparator: Alternate Nostril Breathing Phase II

Alternate nostril breathing for hypertensive women in 3rd trimester of pregnancy

Behavioral: Alternate Nostril Breathing
Utilizing Pranayama (deep breathing technique) in normotensive and hypertensive women in 3rd trimester of pregnancy

Active Comparator: Bhramari Breathing Phase II

Bhramari breathing for hypertensive women in 3rd trimester of pregnancy

Behavioral: Bhramari Breathing
Utilizing Pranayama (deep breathing technique) in normotensive and hypertensive women in 3rd trimester of pregnancy

Active Comparator: Sheetali Breathing Phase II

Sheetali breathing for hypertensive women in 3rd trimester of pregnancy

Behavioral: Sheetali Breathing
Utilizing Pranayama (deep breathing technique) in normotensive and hypertensive women in 3rd trimester of pregnancy

Outcome Measures

Primary Outcome Measures

  1. Change of blood pressure from baseline in normotensive and hypertensive women in 3rd trimester pregnancy while utilizing various pranayama breathing techniques [One visit, 15 minute intervention]

    Continuous blood pressure monitored while participants engage in a deep breathing technique (pranayama breathing)

Secondary Outcome Measures

  1. Change of heart rate from baseline to after the intervention [One visit, 15 minute intervention]

    Continuous heart rate monitor will be applied

  2. Change in body temperature from baseline to after the intervention [One visit, 15 minute intervention]

    Continuous temperature monitor will be applied

  3. Change in cardiac output from baseline to after the intervention [One visit, 15 minute intervention]

    Continuous cardiac output monitor will be applied

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Any pregnant woman in the 3rd trimester after 28 weeks of pregnancy who is/has

  • 18 years of age or older

  • English speaking

  • Phase II Only- Chronic hypertension - defined as pre-existing elevated blood pressure prior to pregnancy or less than 20 weeks gestation (Systolic blood pressure greater than or equal to 140 mmHg and /or a diastolic blood pressure greater than or equal to 90 mmHg) with or without antihypertensive use

  • Phase II Only- Gestational hypertension - defined as elevated blood pressure (Systolic blood pressure greater than or equal to 140 mmHg and /or a diastolic blood pressure greater than or equal to 90 mmHg) after 20 weeks of pregnancy without any evidence of end-organ damage or proteinuria, with or without antihypertensive use

  • Phase II Only- Preeclampsia without severe features - defined as elevated blood pressure (Systolic blood pressure greater than or equal to 140 mmHg but less than 160 mmHG and /or a diastolic blood pressure greater than or equal to 90 mmHg but less than 110 mmHg on two or more occasions 4 hours or more apart) with evidence of proteinuria, with or without antihypertensive use

Exclusion Criteria:
  • Any unstable maternal or fetal condition that requires urgent delivery

  • Any concerns for pre-eclampsia with or without severe features (i.e. Development of HELLP syndrome or eclampsia)

  • Severe pulmonary disease

  • Active or acute pulmonary disease

  • Known deviated nasal septum

  • Does not desire to perform breath-controlled exercises

  • Low blood pressure defined as baseline blood pressure less or equal to a systolic of 90 mmHg and/or a diastolic blood pressure of 60 mmHg

  • Cannot roll their tongue

  • Have difficulty or cannot breathe through their nose

Contacts and Locations

Locations

Site City State Country Postal Code
1 Advent Health Birth Center Merriam Kansas United States 66204

Sponsors and Collaborators

  • Children's Mercy Hospital Kansas City

Investigators

  • Principal Investigator: Shilpa Babbar, MD, Children's Mercy Hospital Kansas City

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Shilpa Babbar, Physician, Children's Mercy Hospital Kansas City
ClinicalTrials.gov Identifier:
NCT05341921
Other Study ID Numbers:
  • STUDY00002180
First Posted:
Apr 22, 2022
Last Update Posted:
Jul 20, 2022
Last Verified:
Jul 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 20, 2022